Novel strategies in antifungal lead discovery.
There have been significant developments in fungal genomics over the past year. The recently released genome sequences of Aspergillus fumigatus and Cryptococcus neoformans have provided unprecedented opportunities for comparative genomics studies of many clinically relevant fungal pathogens. Emerging experimental analysis tools, such as fitness profiling and protein microarrays, have greatly enhanced our ability to conduct genome-wide functional studies.
D000935:Antifungal Agents / Q000494:pharmacology; D019295:Computational Biology; D015195:Drug Design; D016681:Genome, Fungal; D023281:Genomics; D009181:Mycoses / Q000382:microbiology*; D040901:Proteomics; D013678:Technology, Pharmaceutical / Q000379:methods; D014774:Virulence / Q000235:genetics
D000935:Antifungal Agents